SpyGlass Pharma Inc is a United States-based ophthalmic drug delivery company. The Company is focused on developing and commercializing long-term, drug delivery solutions for patients suffering from ophthalmic diseases. Its lead product candidate is SpyGlass Drug Delivery Platform with bimatoprost, which is designed to deliver three years of bimotic anti-inflammatory therapy to targeted tissues in the eye.
Ticker SymbolSGP
Company nameSpyGlass Pharma Inc
IPO date- -
CEO- -
Number of employees- -
Security typeOrdinary Share
Fiscal year-end- -
Address27081 Aliso Creek Road
City
Stock exchangeNASDAQ OMX - NASDAQ BASIC
CountryUnited States of America
Postal code92656
Phone
Website
Ticker SymbolSGP
IPO date- -
CEO- -
A total of
0.00
USD has been distributed in dividends over the past 5 years.

No Data